Received: from DB5PEPF00014B90.eurprd02.prod.outlook.com (2603:10a6:10:46a:cafe::aa) by DUZPR01CA0083.outlook.office365.com (2603:10a6:10:46a::19) with Microsoft SMTP Server (version=TLS1_3, cipher=TLS_AES_256_GCM_SHA384) id 15.20.9870.25 via Frontend Transport; Tue, 5 May 2026 06:36:16 +0000 Received: from DUZPR01CA0083.eurprd01.prod.exchangelabs.com (2603:10a6:10:46a::19) by DU4PR02MB12199.eurprd02.prod.outlook.com (2603:10a6:10:62c::18) with Microsoft SMTP Server (version=TLS1_2, cipher=TLS_ECDHE_RSA_WITH_AES_256_GCM_SHA384) id 15.20.9870.25; Tue, 5 May 2026 06:36:16 +0000 Received: from westeu12-emailsignatures-cloud.codetwo.com (13.93.42.39) by DB5PEPF00014B90.mail.protection.outlook.com (10.167.8.228) with Microsoft SMTP Server (version=TLS1_2, cipher=TLS_ECDHE_RSA_WITH_AES_256_GCM_SHA384) id 15.20.9891.9 via Frontend Transport; Tue, 5 May 2026 06:36:15 +0000 Received: from DUZPR08CU001.outbound.protection.outlook.com (40.93.64.67) by westeu12-emailsignatures-cloud.codetwo.com with CodeTwo SMTP Server (TLS12) via SMTP; Tue, 05 May 2026 06:36:14 +0000 Received: from GV1PR02MB8353.eurprd02.prod.outlook.com ([fe80::bac:5de1:56c4:91ac]) by GV1PR02MB8353.eurprd02.prod.outlook.com ([fe80::bac:5de1:56c4:91ac%3]) with mapi id 15.20.9870.023; Tue, 5 May 2026 06:36:10 +0000 Received: from GV1PR02MB8353.eurprd02.prod.outlook.com (2603:10a6:150:54::21) by GV1PR02MB8380.eurprd02.prod.outlook.com (2603:10a6:150:5b::5) with Microsoft SMTP Server (version=TLS1_2, cipher=TLS_ECDHE_RSA_WITH_AES_256_GCM_SHA384) id 15.20.9870.25; Tue, 5 May 2026 06:36:10 +0000 Received: from DU4PR02MB12199.eurprd02.prod.outlook.com (2603:10a6:10:62c::18) by VI1PR02MB5024.eurprd02.prod.outlook.com with HTTPS; Tue, 5 May 2026 06:36:19 +0000 From: "Kristi Sarap - RA" To: =?Windows-1252?Q?Viktoria_=8Eigulina?= References: In-Reply-To: Subject: =?Windows-1252?Q?Vs:_PRESS:_Postimees_k=FCsib?= Date: Tue, 5 May 2026 09:36:10 +0300 Message-ID: MIME-Version: 1.0 Content-Type: multipart/related; boundary="----=_NextPart_000_0064_01DCE3A0.8E2368B0" X-Mailer: Microsoft Outlook 16.0 Thread-Index: AQJVYzGN+OfHHOZuNZzED7ytP3QieQKxpXRv Authentication-Results: spf=pass (sender IP is 13.93.42.39) smtp.mailfrom=ravimiamet.ee; dkim=none (message not signed) header.d=none;dmarc=none action=none header.from=ravimiamet.ee; X-MS-Has-Attach: yes X-MS-TNEF-Correlator: X-MS-Exchange-Organization-Network-Message-Id: 51492acb-854d-434b-4552-08deaa709b82 X-MS-Exchange-Organization-AuthSource: GV1PR02MB8353.eurprd02.prod.outlook.com X-MS-Exchange-Organization-AuthAs: Internal X-MS-Exchange-Transport-EndToEndLatency: 00:00:03.6295413 X-MS-Exchange-Processed-By-BccFoldering: 15.20.9870.020 Content-Language: et received-spf: Pass (protection.outlook.com: domain of ravimiamet.ee designates 13.93.42.39 as permitted sender) receiver=protection.outlook.com; client-ip=13.93.42.39; helo=westeu12-emailsignatures-cloud.codetwo.com; pr=C x-ms-exchange-organization-originalclientipaddress: 146.255.183.65 x-ms-exchange-organization-originalserveripaddress: 10.167.8.228 acceptlanguage: et-EE, en-US X-OlkEid: 000000004C30E2D3CD34B4428531CBEB8A7CAB89070034AD76187591974DBF6C4F76951C873A0100020000000000B04CDEF8D3227A448511457FBBCE9C870000000008920000432CFAC559F81F47B9D16D8CEC7D6D6B X-MS-Exchange-Organization-SCL: 1 X-MS-Exchange-Organization-MessageDirectionality: Originating X-MS-Exchange-Organization-AuthMechanism: 04 x-ms-traffictypediagnostic: GV1PR02MB8353:EE_|GV1PR02MB8380:EE_|DB5PEPF00014B90:EE_|DU4PR02MB12199:EE_|VI1PR02MB5024:EE_ X-MS-Office365-Filtering-Correlation-Id: 51492acb-854d-434b-4552-08deaa709b82 X-MS-Exchange-AtpMessageProperties: SA X-Microsoft-Antispam-Untrusted: BCL:0;ARA:13230040|366016|6049299003|31052699007|39142699007|8096899003|18002099003|22082099003|56012099003|55112099003|41050700001; X-Microsoft-Antispam-Message-Info-Original: 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 X-Forefront-Antispam-Report-Untrusted: CIP:255.255.255.255;CTRY:;LANG:et;SCL:1;SRV:;IPV:NLI;SFV:NSPM;H:GV1PR02MB8353.eurprd02.prod.outlook.com;PTR:;CAT:NONE;SFS:(13230040)(366016)(6049299003)(31052699007)(39142699007)(8096899003)(18002099003)(22082099003)(56012099003)(55112099003)(41050700001);DIR:INT; X-Exchange-RoutingPolicyChecked: LW4SwLWwnBUWewg2W0ub8/1nKV5DWbcuyToBSaEfGBuMRrZSTHJcb5i8MwsQU6VSg3rIAiAYcHlPHRuT5PAPAxSi9le/SLQEpsS803IxReIQmmN4MXlo19vsJn/QjXQaxnn01MRRa6NBMoZMoX1nrGoolywBC5CODPmMlJpHMKcPsxpcZcecXb8enH9cDx9SCgymkDqCYEc/Ub2RalvK3/SEiXZeiF8Z6hTLpMW4a1gLf5YznTkw+WMWgwPw9qHJt5eC7/2xl2CEG2IFloDB7q8nI28NUdLC0WSVjjkver9SRjvwS7PxOGPKwgneDWamR5DG79hBE9WvUQiGQshnGw== X-MS-Exchange-Transport-CrossTenantHeadersStamped: DU4PR02MB12199 X-MS-Exchange-Transport-CrossTenantHeadersStamped: GV1PR02MB8380 X-OrganizationHeadersPreserved: GV1PR02MB8380.eurprd02.prod.outlook.com X-CodeTwo-MessageID: 9b0f0c96-e3a8-401e-b692-94899c3ce0b5.20260505063614@westeu12-emailsignatures-cloud.codetwo.com X-CodeTwoProcessed: true X-MS-Exchange-Organization-ExpirationStartTime: 05 May 2026 06:36:15.5254 (UTC) X-MS-Exchange-Organization-ExpirationStartTimeReason: OriginalSubmit X-MS-Exchange-Organization-ExpirationInterval: 1:00:00:00.0000000 X-MS-Exchange-Organization-ExpirationIntervalReason: OriginalSubmit X-EOPAttributedMessage: 0 X-MS-Exchange-Organization-Recipient-P2-Type: Bcc X-CrossPremisesHeadersPromoted: DB5PEPF00014B90.eurprd02.prod.outlook.com X-CrossPremisesHeadersFiltered: DB5PEPF00014B90.eurprd02.prod.outlook.com X-MS-Exchange-Transport-CrossTenantHeadersStripped: DB5PEPF00014B90.eurprd02.prod.outlook.com X-MS-PublicTrafficType: Email X-OriginatorOrg: m1wmgpm3xrpm87txzdfw82by7.smtp.codetwo.online X-MS-Office365-Filtering-Correlation-Id-Prvs: b2ba7937-dbaf-4145-88aa-08deaa709876 X-Microsoft-Antispam: BCL:0;ARA:13230040|39142699007|31052699007|366016|6049299003|82310400026|35042699022|8096899003|22082099003|56012099003|18002099003|55112099003|41050700001; X-Forefront-Antispam-Report: CIP:13.93.42.39;CTRY:NL;LANG:et;SCL:1;SRV:;IPV:NLI;SFV:NSPM;H:westeu12-emailsignatures-cloud.codetwo.com;PTR:westeu12-emailsignatures-cloud.codetwo.com;CAT:NONE;SFS:(13230040)(39142699007)(31052699007)(366016)(6049299003)(82310400026)(35042699022)(8096899003)(22082099003)(56012099003)(18002099003)(55112099003)(41050700001);DIR:INT; X-MS-Exchange-CrossTenant-OriginalArrivalTime: 05 May 2026 06:36:15.4758 (UTC) X-MS-Exchange-CrossTenant-Network-Message-Id: 51492acb-854d-434b-4552-08deaa709b82 X-MS-Exchange-CrossTenant-Id: 8fe098d2-428d-4bd4-9803-7195fe96f0e2 X-MS-Exchange-CrossTenant-OriginalAttributedTenantConnectingIp: TenantId=8fe098d2-428d-4bd4-9803-7195fe96f0e2;Ip=[13.93.42.39];Helo=[westeu12-emailsignatures-cloud.codetwo.com] X-MS-Exchange-CrossTenant-AuthAs: Internal X-MS-Exchange-CrossTenant-AuthSource: GV1PR02MB8353.eurprd02.prod.outlook.com X-MS-Exchange-CrossTenant-FromEntityHeader: HybridOnPrem X-MS-Exchange-ExternalInOutlookResult: NotEnabled X-Microsoft-Antispam-Mailbox-Delivery: ucf:0;jmr:0;auth:0;dest:I;ENG:(910005)(944506478)(944626604)(920097)(425001)(930201)(20251009189)(140003); X-Microsoft-Antispam-Message-Info: 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 authentication-results-original: dkim=none (message not signed) header.d=none;dmarc=none action=none header.from=ravimiamet.ee; msip_labels: MSIP_Label_defa4170-0d19-0005-0004-bc88714345d2_Enabled=True;MSIP_Label_defa4170-0d19-0005-0004-bc88714345d2_SiteId=8fe098d2-428d-4bd4-9803-7195fe96f0e2;MSIP_Label_defa4170-0d19-0005-0004-bc88714345d2_SetDate=2026-05-05T06:36:09.509Z;MSIP_Label_defa4170-0d19-0005-0004-bc88714345d2_Name=All Employees (unrestricted);MSIP_Label_defa4170-0d19-0005-0004-bc88714345d2_ContentBits=1;MSIP_Label_defa4170-0d19-0005-0004-bc88714345d2_Method=Standard; This is a multipart message in MIME format. ------=_NextPart_000_0064_01DCE3A0.8E2368B0 Content-Type: multipart/alternative; boundary="----=_NextPart_001_0065_01DCE3A0.8E245310" ------=_NextPart_001_0065_01DCE3A0.8E245310 Content-Type: text/plain; charset="Windows-1252" Content-Transfer-Encoding: 8bit Tere, Viktoria! Ravimiameti poolt vastab järelevalveosakonna juhataja Liis Prii. "Arst kirjutab ravimeid välja patsiendi ravimiseks vajalikus koguses - selleks võib olla ka üks tablett. Kui see kogus erineb ravimipakendis olevast ravimi kogusest, annab apteeker enamasti lähima suurusega ravimipakendi (nt arst kirjutab välja 28 tabletti, aga pakend on 30 tabletti). Erandiks on narkootilised ja psühhotroopsed ravimid, mille puhul ei või apteeker väljastada ravimit suuremas koguses kui arst on määranud. Apteegil ei ole keelatud ravimit pakendist välja lugeda, st apteeker võib pakendist võtta ravimit täpselt sellises koguses nagu arst on määranud, selle ümber pakendada ja väljastada. Erandkorras seda võimalust kasutatakse (näiteks tarneraskuste korral, kui ravimit ei jätku või asenduseks on saadud tavapäratult suured pakendid). Pigem on see aga töömahukas ning kõik sellega kaasnevad kulud jäävad apteegi kanda (pakendis üle jäävad tabletid lähevad enamasti mahakandmisele, väljaloetavad ravimid tuleb sobivalt pakendada)." Ikka head Kristi Sarap Ravimiameti kommunikatsiooninõunik kristi.sarap@ravimiamet.ee _____ Saatja: Viktoria Žigulina Saadetud: esmaspäev, 4. mai 2026 10:19 Adressaat: carmen.katariina.sikk@ravimiamet.ee Koopia: Kristi Sarap - RA Teema: PRESS: Postimees küsib Tähelepanu! Tegemist on välisvõrgust saabunud kirjaga. Tundmatu saatja korral palume linke ja faile mitte avada. Tere! Meile kirjutas lugeja, kelle sõnul väljastati talle retsept seitsme tableti peale, kuid ta ei saanud neid Tallinna apteekidest kätte, mistõttu muudeti retsepti. Palume teid kommenteerida: * Kas Eestis saavad arstid välja kirjutada ravimeid ka üksikute tablettidena? Kui jah, siis millistel juhtudel see on võimalik ja milliste ravimite puhul seda tehakse? * Kas apteegid saavad ravimeid müüa ka üksikute tablettide kaupa? Ette tänades, Viktoria Zigulina Rus.Postimees ajakirjanik viktoria.zigulina@postimeesgrupp.ee ------=_NextPart_001_0065_01DCE3A0.8E245310 Content-Type: text/html; charset="Windows-1252" Content-Transfer-Encoding: quoted-printable
Tere, Viktoria!

Ravimiameti poolt vastab j=E4relevalveosakonna juhataja Liis Prii.

"Arst kirjutab ravimeid v=E4lja patsiendi ravimiseks vajalikus = koguses - selleks v=F5ib olla ka =FCks tablett. Kui see kogus erineb = ravimipakendis olevast ravimi kogusest, annab apteeker enamasti l=E4hima = suurusega ravimipakendi (nt arst kirjutab v=E4lja 28 tabletti, aga pakend on 30 tabletti). Erandiks on narkootilised ja = ps=FChhotroopsed ravimid, mille puhul ei v=F5i apteeker v=E4ljastada = ravimit suuremas koguses kui arst on m=E4=E4ranud.
Apteegil ei ole keelatud ravimit pakendist v=E4lja lugeda, st apteeker = v=F5ib pakendist v=F5tta ravimit t=E4pselt sellises koguses nagu arst on = m=E4=E4ranud, selle =FCmber pakendada ja v=E4ljastada. Erandkorras seda = v=F5imalust kasutatakse (n=E4iteks tarneraskuste korral, kui ravimit ei j=E4tku v=F5i asenduseks on saadud tavap=E4ratult suured = pakendid). Pigem on see aga t=F6=F6mahukas ning k=F5ik sellega kaasnevad = kulud j=E4=E4vad apteegi kanda (pakendis =FCle j=E4=E4vad tabletid = l=E4hevad enamasti mahakandmisele, v=E4ljaloetavad ravimid tuleb = sobivalt pakendada)."

Ikka head
Kristi Sarap
Ravimiameti kommunikatsioonin=F5unik
=
Saatja: Viktoria = =8Eigulina <viktoria.zigulina@postimees.ee>
Saadetud: esmasp=E4ev, 4. mai 2026 10:19
Adressaat: carmen.katariina.sikk@ravimiamet.ee = <carmen.katariina.sikk@ravimiamet.ee>
Koopia: Kristi Sarap - RA <kristi.sarap@ravimiamet.ee>
Teema: PRESS: Postimees k=FCsib
 

T=E4helepanu! Tegemist on v=E4lisv=F5rgust saabunud kirjaga.
Tundmatu saatja korral palume linke ja faile mitte avada.
Tere!
Meile kirjutas lugeja, kelle s=F5nul v=E4ljastati talle retsept seitsme = tableti peale, kuid ta ei saanud neid Tallinna apteekidest k=E4tte, = mist=F5ttu muudeti retsepti.
Palume teid kommenteerida:
  • Kas Eestis saavad arstid v=E4lja kirjutada ravimeid ka =FCksikute = tablettidena? Kui jah, siis millistel juhtudel see on v=F5imalik ja = milliste ravimite puhul seda tehakse?
  • Kas apteegid saavad ravimeid m=FC=FCa ka =FCksikute tablettide = kaupa?
Ette t=E4nades,

Viktoria = Zigulina

Rus.Postimees ajakirjanik

viktoria.zigulina@postimeesgrupp.ee<= /p>



------=_NextPart_001_0065_01DCE3A0.8E245310-- ------=_NextPart_000_0064_01DCE3A0.8E2368B0 Content-Type: image/png; name="Outlook-lxejmpoo.png" Content-Transfer-Encoding: base64 Content-ID: iVBORw0KGgoAAAANSUhEUgAAAPIAAABCCAYAAABtoovRAAAQAElEQVR4AexdCYAcRdX+qqq7Zzcn 4QoQ7kNFUEQUBfQXBMEDUAIBFQI5dpdLEFAOEQgBBQUkIPdmNwkEFQgCIgoiIv6/oOKFAooiN0Hu hBy7O31U/d+rmZ2d2Z2ZnQ1JuLa3q7rq1TuqXr1XV8/Magxfq18DR7u1MLVrIx9a3HjMcHX6wSlM 694cLe6zaIuPR0tPB1qT05g/CNN63o1JLlr9DRiW+GbTgPbGdLg7Bq3x6wvCoyWejtaez+BIt/mb raFvmvq09WyBfPILmPB3DL8HknvwXH6vqvWbmuyMNns1jP4rAvwMCC+EjqZDBWczfx20ehjj3I/Q mn6mKv0w8B2jAU1j+CSa8H3kwtcXIvIIww44tQCJvQXT4h+iLf9ltP0pfMdos5GGOuyHMNwBJpjA sAGC8D1weO8A0pb4o9B00khPhorGIE0BKyErPCWvAoNQTYSz12N6OmkAj2HAO0YDGtbk0MP29tBI ehKg0UB7ogEC8swz6o6BlE8djUSo34em8EtwAR37/b9AS/JJShi+JzlDfX0BlqrIqGvLREa9K03l EVZ+KxxIh98YoltLXK9sR4yy4KjvPMuawtGw9igWDt/vUA1wRkYessvSQWMqUApwziGJ70c+/jni /AMAYZoTr6NhitElNK6YQelmBOFuUO4WTM9/A8e7Zqy+680naUz+KzBmR1g3eN2cd3fiUbeMa9/F cuVkOK6NNlzyttaARhj+Bl3JPNikh0s9DHopIygZXHQCOnKfQyb7s+QCOJtBaSnrC71OrTljBNE5 WJK/4B271JazAxOcCh2EcJyF+7RUPWUwH2n+QUTUqeYgqTjQiu5Fx/7JfhB4RHh3+ix1f0F1RsPQ d4IGNK5UT6Izmsppdib3YHkepDTWbp2O8ojzRj0PlTsVWXw7DI3LA/tFsozkJI4gdxTSbY/oV/r2 zk66wfiDRITzoM26EF000uKror9xNT0RSXo+B9n/cKDMw3EdLqseJ3sYxOyv55Hai6Ds59AZ/qoR tsM4b08NcLgvNkxFN3H/thhaFQFDeLSrhE7MU1ShqUEvBzVSZPQ3eRD2IcFcoXCkG4dpbgO+ftnQ n7hPdetgimtaIV7ViCa7kWhz63veLW581RXEMY/mcPArYzDp1bGAk1YN5DT9tTXR0r0r1thvAaAv gtbrIk0G4hUgywuPfnFn03/QHp7Eg8iPQpmPk89BUOpEYk2G03sA+Q+g3RzPldHfCVt19zGu0N5p L43GUS8WBvCGpVE/U9waXp/Tlm/g9dYw7SCIbUvWZl9tgVa3jQ9H89niNqNtjIf00SDkQy6e7tb0 rwJb833y2twWXt7rfQ0odn2Em4CpbiPPb9dfBwPqJ7Y5zY2G9EO/Ql3KK2goGe6xgpd+AlnWQ0Or Tc8JBWE4npJOHJKip3Rvipb0ALRmFyJJboDK3wmX/IrLVIb4VoRJBw/UvoZpXR+rLXyQkin596El Pg6hmweX3u55I/kZ7AcuR0v+ED94CIsWNx5dm1yCkeOuxZpjfoDpyZHo7UQ5zGpJdsWR2XFwzXRg 82vy2Q9K6+ozsROOHAvwCbS6g3mO8EWIsbe5ERzsWnF4dg5akrOQT4+Ciz8Nl20Lh5FweiueLO4K lWtl3c7CEdm3SPtlGnXoGe7qArQmexF+FtqSbxNnkJCdi2npwRCH9QyKkeiz1X0V3Uk7mkddCzPm GsRjrybfb6Ote7ciVvXHlGXrobV7MlrsRTDx9Rzo7+arszvQPOZatGRnYXryP9UJB4G2cfBsSz9H W/gesuhmZPEfgOwhwD6EBA9RT/cB8W3o3uQqtMRTMb1ny0E41i8W52nJT0Rb9l3o5EZoQ/6mT16W yCvEn2ENexWmdbcOWV5rsrPXh9h1mvwSOv41kP8ZtvqfS9lvB5QGvunx9gjTeVAZ+2HcNZgeH1Ze cV3KKEhaYUUva5fw1HoRVI3ltfB1NNyUweHT6Nn0owKqG1peGI/W/BmIuFowZgFCfTyCcA8EuW34 fBfDVgiij/J5MKLgAujwJ2iNr8FQTsnF+ab3HE/6WxCFs5BTB0AH25HnVjB8TRSaFgTRfCr4Rir2 m0ByCQejVhi1DwLzOcCdjHHd6/l2jMMoODeL+1qG8JNeF1kKLoF98YBIxk1HfQThoWjCtZTzI8re GYi34KB6Pvl8A1FwOsNZ1IGEmQiDM5mfyedZDGcTfjpyXOVAfYs9OM7L2Ag5WPtV0p+OgPvyKDqV eLVDsz6FBnIWFi8b6+mnd+1CQ/kRTO4nPAi9CCHrF0T7wERfYB0nwuhTgegnmNZzKVqWjfc0vZEf ROJWRE0/hm66hnU4FmG0J2m3hAnex/rsw/qeTv3dgpae8zBlCKupafn9YUfdyMHsNtrCCQhyHyPf tYCi2Yo+TbQeYR9inQ9jmAMT3sy2fJWD3AgM9WpJJ6LZLYAKf0x5J5HXbtCciEryMhC2NsMOLJ/C NrczfTNt8AiIHurJkxm4NfkulLrV60Ps2oRbI4i2gMkJv8NhogUcQPlqMX8a8S5DLjgAkdkXOfMF KPv1cvbivOX5FU8rmpFSg/PjmRiawjEA9mKofU/v2QdY41Y2ZiYNZ3sInZyEpwnYkVQgSRWDwBPC pMwEayIKJwPqejrzDEx+fiTqXc4pjKUyTXgBZWwO4SG8ZB8rQXjLdjRjhwXRTqwLnSWcxJUHuDIA YguYYENk4UZeTIgAihuUmDlfT9L5yjJf7xbcPB06jen1RHSqqcRH6tQbpG7loRcu8oAu7poDUhdu x3oItxJOUUdV8yRRfHuhw9Foi4+k4d7IPvoitF4TedKJTKljbxCY0qORyx0Nl2vHl7jEJQsc2jUB WyYd0OYKBGbnij4TfUoQHp7ejEOQOxFBch5kMBX6WmHKE01oTb7HQWAe+3cPKJqZtEP4yZbNMB8w yNOyvgKXOidUgNHb0qEv4jnDVTh6yVq1RFTAZelacLKr+Z7+M5A+lDpL3R37VGSFlKcNyBcQeVKf tChPm0uxVf4S1HpLM82Npv3MQhicBG3W8joW3sJHgthdQjnyDKNPI4jOhgl24nkJSMfA2jq1NmQb waTcrI08VmegwbKO7OSP44il61aVPD0+nJ01nyP5jsjoLNIpMtoKsuHqMUteQ098Hxv1KGdAQCn4 S5SQF2UajpLBmWhaex6OoHH5wirR4fGXoHAclNbkhYpLUTWGHaUZAgZxZlGsnDj31kXeEGnSwu3o aR2dATbi7ApIPT1wkEgp0DiBJj4DHkGnZGqyl+DU8xwWSEw440FvBUd8KpeYhk6s1KPUXQwdEDDI 7Ujm0ESj/T4ydzGCYD1vXFlSm1DKUvZNGOyLkbmvYWr8QYThjxgO4/7d+EGxpKcqbISeYqn/VoyJ OWhXwRHQJC6lcxv9kHU6AUqP8nzFeaWMxFAGhD3C+t5NQ38WmvYhcF9OAWI7ls8oPAQ9uQs4aES+ qFZ0lBsFM/ZSyqOTUZ44sMuK2OwLlznKe9jbXxr/t7KfKUfkOW0Q5I7A0vz3MMPpInHfQ8cnIwwP Q0L9iQP3lQCa/SVtIguI/clgJHYnKzt2sUelGCi1Bly8k88zGiiEwFV+UxeUsR3SqLAkZaZ0T89P 4rLrfAThWO9cJSUSQ5zLZa9A62MwJ7cLl4N7Qbm7Ydh4KCLIzVaKkciHLUJzAJLw4qrLqjY3lkZ7 IhVq/IgqpL1BiVpcD5Lui5GlJyGJ74CmwSgGR/69eJKUALULnFO4XC1jfS5Bj72SB1uPQQufXuQq T8Vya/PIx7ciby+hrLMB+xdc2fwklD0O3fEfIXKrkNYFzVM9cOEM8juL/JYNykMcQ5vNYKLPQoch ZGapK6BYKH0jAy3UcdDuxwiCj/MUnSI5mBZR6j6kn6KQqw/1BfQZfB9JmwsxZuSFMGY/z1fw+0qB kP3u0nsQpHthTrQ7lPsCbLyQ+OVYhfokDjDhFIzpOaSysCwn8vL5WZCtjgxS1eRZ3Akb7gaxP6On wGUvDJTHAVB8X5k2PBcfWCYBaMu/h/54FIdrkLaiyPdTmr7IfpvBPjiFA9PvEbCN3rZZ/15sR+Yh 9QZVmEAI1wxvwG2BMDca0GtXCJ+afy/rPAs6GE1HqCjymYiOlNmbMDuY7/MdzU/AuXY2vMsrwQOL kTRWRrzAcF+Vck9XhPc+snhPQG0N2bOj36Upx7mnsGHzCegIz4eNDqSBnA7L4dOEZci9ynUfxlQU 9pezm2fjCnMkO+n+AXUqo/RJLwfLOSCdi6vMsZR1BubRiaWwo+mXMPpEKAUojSFfc9RS6rCTe+WF 0A3QO7aFNzTlmQCQdqpG6GhUSjchiDb1dRQaTXod+uygEU2BffgeLMQ6A3DT/BHkO83PXNKf5QhK 0RE84Bq0j3japzqiP8OqWwo6Ux5UilwK3zao4yEHZqWCsoRNjoSOWiCD0wB5tAk/K6pbMFe95Kna wzvh7J2QpbYHlEWyxNeBgVOnVkwkVvOMIRoHmWXL0H3S83F/RWd4FsN3ESYH0KEvAhR8f6B4OSpN +fS2mOKaJNVATwnaSg7OFRg6tXkhwXgGlyBKz0QYTWDlCeh3KypSHBO4v6JExQ9RmZylCy2rKJPO UIQrdySmJR+rKFP6I2iKclUVWqjeeDy1fBtPI04xO/ctwH2d+EmlUomh3DpQPdsxVbjlpFPrXCEz SKzYS0oXBoH+qMq+ikJd+pc0lrcjqTSw1xtAFz25rJvO/w8OjDfD5v9GvVK6aoCYaJZi0uRhrm5m FUL8XzTizCQF1GiofKUOWvJbQ+tvUjtUOwcL9LsUB4skzbOOL1eUKPciZCmNKqbt4WobZKO+UEEj mbb8+wB1EleDYB9jwKXJL7OvAOpfqLjUy76OFbBixstz2wIxJ40SbHdftV4fKIL9Q3Sh1HjIazUB XDliISYEX2OfnMs2OcgAKXAJViK3OaJ4K0mxdvJ4g4Kyfcb+XPx5GPc5VpiVkRbxUX6LoVk5eXJd 5WCYUcuZ51qGcbWbkyj3oGtC2xPQe/gggwbSwgFVNU9xHL1NuAYd9jh43CLjjuj7UPZk9nQCLT5C uIyO0M3szF2YW8m3Cl8Xw4i1sgyDMREDsRlXN1kbTPhhdAT7Y3nPblTNPTB0mLr0dHRNXWT526Di 3dEZneAD3DS4ZEmF8dXmM7DDrTsOYTieg0ptKkVP0axlOYa0pTxfnrYcEKJIkWKvcjD7OODK7CuI ggn15fEFl0JcQWu9W1aA+jKUZyjPYr8STGE9UGVgJUqw3oQs5zW2g42m9oIwU1nMzZ0Kl14ILYRF l80cYPRGHKbfK7hFqCTfkGC91EnOwOqD2XHNdRUpyBpKHqWQSr4SVCrrTchMbsyeWJp+zIP+IcdC OgJ14fP9Iz9astCYg/BcVtnp7eHFPOzgaw0N6JCUxIto7EaXDh4IfGvdYiAWf+Wy8nq0Kw6UyuGH ayzioMp3pNIUJVH1oOjEaeyg9G3oGPVCCSm0D8LZ/xSMOnG4HAAAEABJREFUrwRtLNGydGsoxffm RPd9wWfVm/WyYFRW6Gxlvqyo5DxabYUj3bhS0fPJNlBqbzoFUVwJPDChFBTY8WjskroLtlMf8m9Q 2pxsJZu9nGocZAVpQgUEx+Ow5TtUoEThmTyruR0R9S06Fya5IIDD9oKnJXrDggMrTelj420Yf0Tq xufKv2UkDsxIStujyDwrPms/ZD9kSOOSM7nH2bgPUVnk7Nk8tfw9+RFcVKFT6xNvBAFvzVtzcEvh 91vovTRCNHIp6sRqV4GaKhkoaXUV0AYzTXsjDDZGmjWIPwQ0K7h2PPLJFpLyIcWuiKINkKZY6ZeX p8agedxGQFdImzEMtcXICjI06yMKxO5GlBDlIFVzv51kj0GLzdF1hLdzfkASSAl39SfEwyhVBTsj F2y4ShRJ9v6WPnJuHxzKd4kLVEZlihp8Uc1IOjZs2pH7xTMww/XpSvYuzdF+3Lu0wmVnIE6/CaVO wSJ5/VST29u7QIOWtRKaKO/+nd2lYKyDd9GQJcos6dx4buM28bTyuglut0LtK8ciX75SIjsaidsE 658nK5bugqw6jGUAU9HeyOKKD31gdvQAkmxvOPtV2HQG7e4UaHWZcNISvSFBul3jScjlsp3kwXVN 4bEqYjmMUXprRKP94QBlvTioQh07NqUx6XA6/pscVVGty9Xz3At2oCM8m+EczA7vggwQFUjDmSFr oHm8HIB+hHvWIZM2RCB9GnDj79xaHr8rvz6U/tgqlacwBkZvgpkzaUxu8ANMRzTxD6O/jtZ0b1/P 3mhe7hG0m++jM3cWbe676Mj9XYreGEeWpUGWdcOppyEfqHd2B2RSnVUZ6JRKmpsU3r3p8GEkqYMy 9YU6VkzoLM5Ca/KJ+sjDpSusgXyRMss2RhitBxl4i6CV+pD+jALNfl/X89XYGkGwFmc5n13pkQwc iocQzkaet3J8RcaU0ozq3FkCaL6GdfZStOS3roPpiwbh5nFWfqQp1tp/ojtaCBVvAKXfvco6rrf2 XqFKcnzNwEeW3cv3hS/AsC7M1r0zrsuDcBxn8PPR0r1ZXdzhwhXTQFNxKFfuPfBd4laMj5xJD0Yp rB3YqUTUajv4vETMD/XW4PTZAJEqtAoquIPbMaCYZaL2nbKKYbgJ63d2tW88lRN6lZUDVjitI2pC vKUBDjIJOvwZP1BLoMwmCMIADeqjAe71UazbyCN0Rn+lY/6FgVnFUO9m08SZw+DDcOH5b+lDrXrN fCPLrKwnpQJu64IpUOeSHWqQwx8t/TkIfa/DW7fhUEWU8J0jl6y5lK+WkGaJeUMXDkwz8zvO/o/A 17EaQTmMbRBnDqL9ocaeWV7SP73yHDlNODY5OmR/Ef3yil6ccDev9P/6Em034ogDHzxgVUVUivSv wpYlCQ7zwapwMCmBaiYc6WMusyOzP7LkHMxooK01mQ0XDNBAQAuQ15DKrTegbCgA5TYFTQziQPXo eudRrTerh1a3bCpysGpD9PKqiuwA8TJbfCPQqV5l/rLGJhAyFLsjCxh1PFrjVkKq3iKiasGQgTob gyBYo7BsqEMdUqTNHoAzPy9g8QSxkFhdcZ/an4tuhk1up5IoWzEMcotxyIt4rb+CZ5Ppg2APFw9F AwkdeSRCWDWBqaFQ9uHKjz1kbh309XBfWSnFfhbH0OAmVIC2+DVMAUp+CEF3rUnsdevWV9HeE/LW 7jniFu40vAlJ8jD9pZAfLLasqg44++N8bu0+Xg2dUqqBVwCmzHsQ+NPA2sQ6BBtANevLICMTZGny Okfg2tJqleRwDDtbSm9XeajgPL5GSiCfThLYYMFy32KM4Yj6TY6QH6iPPlw6JA1sShd0jlY7JKo+ 5NyY90Prd5FLH6x/ShsgH/fAxv/yRVav+ApAZClsCxncPbMqkcjLEr5ycn8vlc5Rz9F+vseVnYMO SuC6CVlih+FYb69HFbeHZQQr7sgWtOgiJ/llCYdJyCTP0UceAwJHQuqQONdDh9cOKF4dAKmaUjl0 xeNL4l4L/o/LsNmFWblBdYhSo3AjOJxX8wP4JQHDiYY0YJocXoOBUiMbwq+GpO0nEIXr1P10YEA7 zPAAzIjf4jOu7yPCWIHL6k8iF43gO93axN6k3F8w6qVfVSCl4Y84ANwJw/pAQkVplQyNN+EYFwQf RZL/Zn8EL6Y/sKG8Vmvx0Gcs5D8ndMdnQ6lP1jx5VgYIOfLkk7sRJF9Du2KNilKcZg2L6dX1yNCn OXn3m7nzuVL4DyLWs6E6sMqJBYLwU8hGTGuIZBipvgaSbodXlo6AcptzgKyPW610Ws+7SddC52Ap +4fxgNtwRRinlnvUS2iDr2EzhEy7AXiNAKa7baH19LrvnzXlJRz1LVd9szbqrmA7T/VA6bMRJ4vB hWxFWb1MxkJrpmF6z6eZKt26lGo0YclJwXAv/G0uT+6E1T+FCk4EtMBQcYkDB2wMX9vxUOlnaAoP RvvI/1bgvBEZ7sQqxBa+Ong+UipdBxVFNTOOepBCpb6K1p53SXI4vA4NhOAesKsHTj3D1BAYuS5O KKQ25yGKNq05G0u/KrJV7mJsGF3H1Ird2i3HMW4MVHIRwmCDmrOxoh3JvJC5KzEnuLWqsM7wXkB9 z7dXNeiKsl8O6VQK38JJbjSKV4PURWz/kAFMKQTRlgijHRGEWwOEuV7DlgaEQMSgyT5NnqJyT0OP OQjyaSi8gZd0pHPLMCF6dEAtXgs7kdlr4Jc6rPcAhCoA+j31IB/1O6ZK6dsctJKbl9GmthifcEZe 1DBn51IoM4FLzUsQBPtC3kBUIzZii+z8LJmHLJyBmcqW0Jw1pfRgCUcjd3oDdGffQhDuXleeLOGT +GrE4YBlcIWYKLgMWfYLhFIN1rGisEbG0t+02QGLksm9GA1abC962VMoRTb9FjkmmqgsCY5HdGny DJL4TmTpGdDh/6A9/Dbmq+Vl1H1JZ4VDX37VpxTOVDH6X7LEjuNvIEn+MqQlNnXKcewgtLgN+7Mc zg9RA0/KQldFDVE574ucxXEmjG6DGHcBhr6LRhrSLmG7kcbnQL18NOaopaXyFBZKLSnl6yWsBRSa eZ5yMbQ5BhknrgHy6IgFeUuRUF4UfQU/UPX5X6EWQduTeQD3X87waOiSA9cgAKyajDY3VmjYUnkM ISiSOLYgn12OfHJsRehJvkJOB9KwJ2Lxo/tAPofcrgq/3sCCgbdyMOaZgfBVAaGSxemUe7Ym9/mj XwTCoyEDURDWRKso8B0crA2kUyvgw5mhaSCkmyxHAu0WMjU4LSdHKD0SJtyMTwWXFmnYz5pGLrOw MTT27PfIp4ehI/dNtG/QVUQqPBbJgW2vfZKuAK0ee3lmHCemzb0sukABkXQ6BOtB06HcNPstT6O/ 6OXJN5YKSPVj+WcECsciS5d7PvWxC6WJBQK1Pbe3nxKAlmhIQXkSC2XnY3Z0SUXoiC5jA27EnOhP WLBt3BBf51bvntnp5+rWq0P9nt17GpXazU6ri+oLpYMDQ0PCnhwd2aMeOhwNVQMp3VdWRVa90Dgp R2bZM4pTiV3K4BvQmZyLuXd9AGlPK1x+IublFlTnuYDTKjh4Vy8dABU5Xh7l9sozIi/rob38mVuz o+B6DkBH088H0A4G6MjdSPrvwAlvMxg2ULC7HJTbQ5C1RCsUlPJT+grRlhM5+yy7ED5gFV5KsfHC 3/1T4rphTnQNl2pXcKEHSIdhkIu6p0I3YRveOwjmcHEtDeiiopX5h9c7lVkLdQC8d/bN7NNcTS3g rP4lhMHH0dncUTpclZ/POdTxTcuStSH/BUSYLDiQjuwel2RlGCQn8jSdzdqnYJP50GZfRIt2Rbu5 Ar0/rjC1ayPID+1Nc+/2/3QAjgY4GN9XLoTNbkIgbjk4Ol/lik3viOluTaEYhPsqLg71C0jjboCK WcWipNUU8/fGxITfRprcxaX/4OiWKM6NRxa/h6nhe0U00MOeETrnHoHos1FH1lwEWfsSdX8eXLoP OqIDcVVwE3qXtY4O1JIeCjXiekTJdbBN10GPvA6t6cEijmLuZwCUQkOXOLHNXoVNzwMob3Z0KK5S v8Tl6y4r0cs/PAhzP4HVd0GldyHK3YzW+Mul8loJWfrr4CS+knoM8rq2Fl4vXLZ1OqDN5d8Ejrw8 kaXNg9ANKrK3EUN9Ko5ZNn0FmXuoIVL55JkNv8GTyechnVePSPZnuZCHNHrLemjDZXU0kCuWGfM0 4vwL0OyvIqjmQ/ll7XI68DGYnTsZHYXv5lbgHwv2SzodgfkkgnAPht3RbD5FmjZMcs0c3B/mgL0M qgF5hT33c3A4HLPDk9Gee7BClmRk4HDqGIR6e+hgAkywIQ+DdyTNlxvaerWrx+D0qVyqLyW9cKwd vCMbtgFbNlD72nxWSskWI14A1H0IsGovzYHCud8jzhX25HLa15L/PFqTb0D+LU1LeggVXbldmKP+ BGe/w862dUdsx7W1IX+FMau2Ee8A7t0vPA6jfgd5fTNYc0PqHPZ6OvD1NVGXQpAczz04gSaFIKc3 VgUYuTiHsbmF7OO/Dj6RKMDQXazIC25ErUspGgMXvVy0c9kNHyjWoy9iXeQftbWmU9CSPx3Tk9No ewdi137/sG2OWYDUXePrNNgAI9KcnsCaeRFvXDRT0Un075DwTF2ZVVQPBfiWqjvQ+xrMxvtQ2A0c 9c6BCmdCm/k8HLkCM1zlkBK/2oEsuQNyiMJ+IE31WxQKdmD10mFooxqYvx5nWPcbnlGQwncan1Vu xbIss4C7u0ppJcjptSoAJIVST2OTB5bhAkV5tAuBQVWgVWQ0bTOOe+DcvRXw/pmvu5Fk47mVioSt Vi9ggYr5zvtYKDMXOjqLNnU2nL4WW+x8Ima4MhrFgSc9F2n8OERuiVHtRBlxbSRfsiqjxPwvXPYw /CZ/iIICLloGI5GTxThdCB3+uoSq9PNMd1HptAXagyjbhAeh/7eaxLCsnoUkWQbDziRRzdt5bjWL hwsa1IDDbdT3k/AfkqhBo9gXmc3T4V+pgVEAN0GceKNCphiL1Wv3BGbulnqIVr9AD7d4YiceUCVS inaC5dB6UZXSPtBr6Xa0gjVKVqkoLKV9Wfdvj6TApbPzScinJIMghDEn4dme3QrAYnzNiIWw6nzy IoA8GNe8FURKzeLVVzBPPQ+nrkNhzV9frkJRC/XRSqVKoTAbYz7a8Y8S3OUfhFMLvaIcFZ1x/WMM NeZO4XJnmxKeJOaEd8G5X0F4QQmkehhq3apzGYZ2Nv2HaqY9UBW1TFTOJULNnbXegFi17yTZi28U RkE+MCJYOgDySTcs7pesD6+FD8DZm8GxATXl0ewU1gBsfXnKfQTajO2TR6ZpSue390Iuk/sDl9sc QMhP7C71dke+wZnc2q0tKKXg8j9GmvyTjl4CDUh4c3Qv03CLRY5NA8i9mK/7IJpDvi7KUAuzoJMH S49CfKk2rWIt++oseDbdkJ0wpmbNZUmcJI9zxu9EYf8iVCi8JuTow/kAABAASURBVHBPFzLFOKV+ o2hT8hr4rSalbkLh95uLyGUPbxwxl0PZk2XQxpKK0gq6bwx/KFjWa4ud1RCRRRPr0hBqFSRpRxVw Q6BqtFF2OfX9b9RaBTk2SwZejW1ryvA/VGAnI4wMxPEFUc4ysuxBJNH/SdYHeX8d4ELksycQ0PE8 sF9kMyCKDKBrH2i2uRHc2x7AOvfJU+Tj1F8xoel3TImHLeTzCdoiH8U7od2FwceQ5s/ADNdn33NH v0SCG/wAU0SteCgyd9ZBJY/3EVE0nGJFK1CrZBw44iiOOJtWKVxx0FzFSuM8JFyH6GAgn4Iipb6V irTZdjBmDdZnII3w4WQL2Asgo/xAjL9DtllK2Eoh25ayw+SfmWUjzkGL6/u6o814WinWowSxMmjC LF4A9J98QQ8U/3qZelDNyLmIuFUaTApjlzNu7FbIEKO7AjklZ4fqvCsQmRG8J8Dpgemh3k7kiCKH SljEd1bsqXJiuHzEM+zXmciyGNKPRdSKR+KY1ftAvoHH1IB7jfSrpN3J97EUagNqCXSMDlyjKpfk s5v+DW3P5WSSkkaw+wXKos9A6wPQ0lXl47iOPRCfiiDamTwKtDoEkpgW6C7FTJV6YA5y/PaAT5ci 4c2MMUdjYXx6hTPLB6YUy6rdvj3ckuZGLqSxOYWWns8i5nsxrcb5dXs1ol6YOJTiMKn16WiJjxyw HOjFW5Hnc0/Nh8uuhIyaikqv4FFsLNRE9H7baKp7LxyOpOK5Uy7oqUSiaL/ewfKX8lTzyhK8IsGD iyyNoaiGXrij3mWJH+SOguXSpiU+FtPS/aFNG+Vo1q8Xs/BU1DJvQN+LjcNCBy2jQzg6oSqg1IxF l0E4Ck5PZOexwmWY8uMHqZnkITJ++ESNiFWmHtaHjncvYbS5ECY+GoGZQGcogasmpL3GfBgb5v3H /Uo4ThpXylVPuAwIeLih9CcKr3OKaBaKdRpMA/D2ZoKNYMxni5R9j0WGp9HuIkg1dNgH703J76gF Zks4dTHa4g/2giG/OtmSPxdKn8GQ8zKUBmS1l8U/xuKXq38ffoNwLit0ibc/HZTYlRIyyGvNbZe5 Cq3xhz18BmfQlmRXtCRzKetE0gNiQ4r2S5HQ6nIE0W0eV6JLVB4KPCWXTFmwCaClgmoGFiZXozU+ gnZ+DHkeDs5tZZjFpIIfopX6OS5Tr2hMz28BE/4AuWBfKBX6ShRRaz5sChizOUxwOdf738E0N7om 7lAKbt8qj9ySk/lC/DrQNtC/82Tpq4L3Qb46OTX5MXRyG4LcNhB4uRzDTjcKSPNXIslRucqVF5fS sf0boJaz3ai4HI1TnCyX24WKvBgquxo6mATvUP1YSYfHSRdceiVmKuv5+F8e0Xw37nO1I+lw4anM oXgmvg2HJzt5ZDk570q+D0NDFF2jn0yPVBaJQSu9LsKABtZzAh0qgotPRhScCKdGQOSUoQ9ISluN GU/c2XSCiQPK6wJYN5mpguAgjMlfwIF9hEePYKHBTvC52pEMIspwaxR8B9N7PleBKEveUcGZ7MfL PTxgv/ZnKctSHX0OmfsJpuXvZf3vYzt+Bh2dAuixkD2oolOFDEl6P7Lo61jQ77vBnjmjmZw1VXga 0mw2RM4AeY42RdsPos9Sxs1e3sL4D0B2A8LwMDoiW81ysYlQg+/DfwEbzkC7opei7HIPgqxoW2Uw Jn0/0nDD8BA4xzYb2kC4fdWBOAzIP3mK+//rSUlVaz0KoV6DS9rCSCLQRkLGusmMB7cnIsjJYCNU g+PIJ2RGh0ciTWfB2i7k2HnSEZ6SrRcnC8N3IRdMpPI246shlhDOmM4GCL6zi5Hx+L45dxzmqR7U ukzzi2z0vyuKRZbwkI73I6ECTDQS3hmKcnoJZMCQtFHnYE7zXZIsBZf9hiehS+CNoQQdmPCGrCM0 R3shzb7rEZ7AWD4/CKPZ+H4yWTDwJo7UL9BrwbkdMKZnfVh3ELQO4AeCgRQDIPJtHv970mrnUpnC I2LPUKoEqpoQ2Vrqqj/B8rUZgOVNL8Gqp2B8rn4kdTRqDOUIfSXuLNWNDXPHsJ9P4Mz0PHI0YBFV wmLbxQHCaEM0RTsjinZCGG4GsROZ5cII1CPYF3dzQGjBPPUk6l3yv68W33Qk7edkZNlLVeXJxGGC CV5eGH0IJreO9x8ZEAPKUwpIen5AB5+GTvXqAHGJfpYDzAtQZcrR7Gr59mCgQTsAVEgmTEvb0O8K iRsnCTKcifboL+Cl2eEpAYChgsQwhxIUOUBxFGqouwS5sXCRWozZ4QnQbgpSdycUG5Rj5aVukpbt WOYAeapivaXcEtjjbmWbDib9qZBlTD2JmyCGNg+A7NHLx6ZdPNW8AXH8czoFIIrt5aE0fF1E6SLP ZYuRpqezsy9A/6uj+Q8cJK70vEXxAetfK5Ctx4N+n2djfE75uBZNNbgCRQqVojDVLClUw6sKM4DQ K79gg7+i7G7u8Z6GDGqi+3pBaJ3TSIv08r5em7lIshjS/nq0YntCD8V6e8mVkax0OqNZcPYA9s3V HJyWQvQv7dDsf0ViGYiSDJQH9j+gDSCOkdkX2UczEYQTMW/Ug5WMa+TkM9id4XkcPA6ivOu56lyK iFXz8vhUmjIsZTHIYE9ThByqyiyZ2X+S7nj0vHY45oys8QWd8En63D+9psSZRTdZ/DwHmw7k4/sg dTeKlWOQtinK68WTdmf2OTgcjTnRPCL5W8MteQr5fCdHn/+wAv9CFjcYkn8hSR+lsfwIY/C857ay o/ZgAZYtmgQbT0JqL0fGo3j5Z+PSOFCJ8rQJ3yWmf2P5hVwC74sRjx2IjuDnDVVFDCTDz5FkCYQX +55LlT+iI/widES52UHI3E2U+zK8MosKzZJXKG8eR9WJ6Ay/VX3A4HI+yZ+HfDKLuv0pHeKWuiGf /pR1XgDnFLW5hIPYTxBnt9WlSeJKnrEjD3UPXI6jPeYgcT9Ff5xa+TgVeTexnb9mPQr3Fc2PM8GZ yT7Itj6KmraR0Bayx6HVXUjwAmkK9wRzC9v+bTrSI0jj2vSJlNmH4PQfC4Q14s7wXnREU4B0X+r/ dKTJr+jUyyBGDumbYrBJN7L8b1iXU+Hyn2d/nol29VoNrrXBc5p/TdovA9m+yKensC9uh+X7ZnpR gYgerBRYjxepm58hTk9EluzHOl4E+fxBAWlgPE8thlF3ezZCHxBFu5+QrpX89yePo5ByReeSPKRt EoiCNH6M7b6YbduPTszlvwALQWPOOksxMnc0kT7JGu0BZA2GdA+kye6IF34D8umYAr+VH/9grSWQ r3i9+uNjEYSfgsJ2cGpbwGzrnwYfgAo+g6vM1zC76TZcwn02hnAF5na2eTuE2Ja8t+VQewjozez4 LszJ3YDg5cNgwo9yqbYLrJ1Ee/kIcT6KVzVHXHY06lzXjHkFj917Epa/dghy0eS6YfmSQxC/ejyU crhd5bH4xTOw7LWD69L057l80SFY8p+5mKOWYkL0HUi+P06tvFs8Ga+9ehg6zK0VLerMXcdl4qfp MDxIq2UbtIXueDfOWqdivlpeopeB8rH7zoFLPgWb1aaXsrRnLywxN5Zo6yU6mu/BVeZbnOknQdkd YLEd++TzyOyhHDg+Buu2R5zbH1epc9Ex4vf1WA1epixEXmf4XZjoS5S5E+2FdqIZTMEGEe6ErujL HNQvwJymfw3Okxg2uAgpivR8qtxphALzRj2PjugKxF3709Y+AJvuSds7iI69A2y0G9t9PDpH3O9x yyIOYczJEnQuj/s7RjzLhjce5pJm3mY95LDqb1nuXKkWoiP3T8xWD5dCe+4ROt1/V7gC7TyIEJ6X kaeEDuqgnJns2dvVY5gd3oeO4EZcqe6HvMqSj9uV49VK37NbChmM5Ns49YLglI/iciAjsHo0/csE v/d74OJEku+PUysvA/qCdZcBHEjQ75Il4lz2dQd1UyvMH/E0hHc/Ukj7hWZuHXopExmN6rRXhvy6 hrw26lB/x+zgVnQG8yGztjhT/9dLvTSv5ymz+hXqcczO9dmf2OIcwn6glgyJ9RwOtrNpcxLE7trV yxX0MgmIbXeEv2TbbsBc7oXnqmeI4xgG3AVHHgAeBgxrYFgDbyUNDDvyW6m3hutaqYHhXEkDw45c UsVwYlgDb10NDDvyW7fvhms+rIGSBoYduaSK4cSwBt66Ghh25Ldu3w3X/O2sgSG2bdiRh6iwlYY+ 7aXRaE32Qkt2IqbFl/J5HKYnu+BgN6aqDPlKXkv+/TjK7YzpXbt43NZkZ0xeum5V/Da3No4l7hS3 XkV5mwv9FwyEl6TLC2e4AIfH25VkHOEoJ94Rk93IcjSflvq05d9TwpW6t1LetOUb+PLhaLVqYNiR V6u6i8Km9GwFs9Z8hMEdyOnz+Oq2jc9ZyAW/RXM8r+rX8kZiNJDNh8a9GNn8W4wiblNwL5qab4T8 A7Mi69LDZXshxL0Ik0klmCS6MQ5W3QqnrobFmgIqhScwFg7XwpBuFGU04beIwj8gl3RWfKVTCNZB MzJc6HFL9SGdzt2Mw912gjIcVp8Ghh159em6IKnNrY9AX4cm9Xkk6S2I44lQek/0JFPgP5YHOoEK C8hlcQQHaIWe7Bl022OxLDkU+WQuIvNxBMFJkBmyDJ3Ylo4GFOK+koAlcHnIj7j7dF8RQpZliCjj fs9/ac+hrNNtaAoPgkqnlWEWkor4PekydKVf9/jdmdRnR6TpWQWE4Xh1aWDYkVeXpnvluHgKmsMP ojv5IRYvmozZnME6wnvQGV2NRa/uDZV9AvKJnl788qfTBi55AYv15cSfz4FgBp35GVi7HdZDUI4K cTK6vn9WFDDj6IBSzuSAW4s72396/p3N87la+C7irIeOvydmcOmNsstCw7nlSJd1evy460TW5zHS 7ES4KsMcTq5iDbylHHkV62L1sJcfEeiOX6OwS+A/EsmU7EEnd22Mces0IU67/S9QHPXiKJZU3orz qzMjMbbrA/6/F2j1cSjF5bBdgjX9/FuJvyI5cXLnRmBXOq3M8tZtBW2ayOolBsvQdysOCI6L67B5 XQ8Mgq252hhBaN/nrX3BcLSqNTDsyKtaw+X8nVOA2wRQzyAOH0XvlYv3xqjc7XDJXYiafgEd3oTu sfv0Fvc9bR5Gbw6YuVDBjdDhFdB6DHlei5kq7cN7Xanl0GYnbJlci7FcNUCfA5c5Lv+voQxbwVkh ZX0oX12Ilpj794D7a7M+4NqhlKvAHc6sUg28/Rx5mtuAJ7ozaVizGC5YDWEWWnv2HUIvWc5YI+G6 +06CrVsC6x4n/GEuSWM0Bx+G1hsP5Kk5B7ouOnKApkiWrwmydDKWNF2L/peD8iClKx1cc+aWWVex PGXwSGWRYznc2qzHjnTIjxDjKS7hj8Kj5o4yrELScYUAHbHe7yf+LlBmMfLxDMSLvl9AaCAW3bXE s1ZDP4ktzPK2ITbSQNXeSij6rVTZhuratNxyBlkGmy2lcS1ZpcG6pV48IZs4AAACU0lEQVSOMj0N 1U1mKesegAk2Q6Q+UaJZmrsT//q//dARHUyn+I24B5Ttm7F7ER1yQPYEbHwo8un/QrlxcMnLqPat IUMujoTWjWfcd4fcS2vIL5Bk0OK0fUXFFE/HcQdMtCNy0Q50zr0wp+lK3FNlxlfcT9vsFdh0IhB9 CMHS3dCZO6vud3HR7xLdSV+JLh0HtFUZRI7LlkFspF813urZt58jXz7qeRre+ZjTfIY3KjGsVRXm 5GZ6Oe3hnQ0bgnGXQn79wQTfQEv6WX/avEBlWGdXh5b8lxCaw9EV/4sOe/9Ank7B0f2CEXTy4AQu a5fD5C7ElO5NB+DG9kksT5YjUFPQuvzDvnyKa0ISH4MR4Toc4B7Cv7EYAy+6t+uGfK3uMvUKn7Kf H4glEMf5Gs5SxovoVK/iijUWCXhIQXQnfSW6XFX91MvXy2k6H2IjQ6rkmx/57efIb3adq4d+wVdO 53FW3ppucD3GxjdwWfl9jI5vgTbXcpYNYXCK/154/7YopaC0IXgEOtSfkWbnIAq2hjHnln70joX+ duHfYO21HBi2AHLXU0YHdLwAYXgaZ/MXKWseqs2yYK00Asxwg9uGg+DQ8XWE4esN1YB0xBtagXec 8PYPJeiMTuHM+EU49yRy0UQ0h5wlo73hsrvQ0/1Zvn66ZYBeFiEj7O+QH1e33D4wg9EvXsz3zzz4 ctuzdHcBlcI81YM4dxLy9lzy3ZgypmMEZdjsj8T9EmaH95VwexNLFmXQ7gHujTnjn9kLrf5MuXRX +hEW/gU5HsIxMXy/cRr4fwAAAP//DNmAOgAAAAZJREFUAwAohokWKMkd3gAAAABJRU5ErkJggg== ------=_NextPart_000_0064_01DCE3A0.8E2368B0--